The firm’s acquisition of a 60% stake in two LBA Logistics portfolios is the latest addition to a growing list of recapitalizations in the market.
5 min read · 01 February 2021
The unprecedented events of the past year have spurred greater interest in listed real estate. Arshiya Khullar explores how that could change the composition for institutional real estate portfolios.
10 min read · 31 January 2021
The firm has raised $8.4bn so far for its long-term perpetual capital core-plus real estate fund focused on a life sciences strategy.
2 min read · 28 January 2021
The executive expects investments in operators to become an increasing part of the French insurer’s real estate portfolio.
3 min read · 20 January 2021
At 2.3m square feet, the research lab and office portfolio purchased from Brookfield is the largest to trade hands this year. But is it worth the price?
7 min read · 23 December 2020
The quest for niche real estate sectors with a positive story is leading many investors toward life sciences assets, providing space for the growing pharmaceutical research sector.
7 min read · 23 December 2020
Looking to grow its exposure to niche property types, the new open-end life science real estate fund was too good for the Dutch pension investor pass up.
3 min read · 03 December 2020
With $500m in its debut fund and $500m in co-invest capital, Breakthrough Properties aims to take life science real estate investment global.
3 min read · 23 November 2020
There are good reasons why the greater emphasis on real estate public equities during the pandemic will stay once the crisis subsides.
3 min read · 19 November 2020
Three of real estate’s most institutionalized sectors are facing long-term, structural headwinds. ‘Niche’ strategies, meanwhile, are pushing into the mainstream.
3 min read · 29 October 2020
